{
  "page_number": 62,
  "text": " \n \n57 \n \nEosinophilic folliculitis \nTopical corticosteroids, \nantihistamines, \nphototherapy, and \nItraconazole 100-\n200mg/day for 3 weeks  \n \nIn patients with \neosinophilic folliculitis, \nHIV should be ruled out. \nFirst-line treatment for \nthis condition is \nantiretroviral therapy. \nFor common etiological agents causing folliculitis, see Annexure B.9.6 \n*In case of long-term treatment if patient is not improving, TDM (therapeutic drug monitoring) for \nitraconazole should be considered. \nReferences: \n1. Jacob S, VanDaele MA, Brown JN. Treatment of Demodex-associated inflammatory skin \nconditions: A systematic review. Dermatol Ther. 2019 Nov;32(6): e13103. doi: \n10.1111/dth.13103. Epub 2019 Oct 28. PMID: 31583801. \n2. IDSA 2014: Clinical Practice Algorithm for management of skin and soft tissue infections: \nDennis L. Stevens, Alan L. Bisno, Henry F. Chambers, E. Patchen Dellinger, Ellie J. C. Goldstein, \nSherwood L. Gorbach, Jan V. Hirschmann, Sheldon L. Kaplan, Jose G. Montoya, James C. Wade, \nPractice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 \nUpdate by the Infectious Diseases Society of America, Clinical Infectious Diseases, Volume 59, \nIssue 2, 15 July 2014, Pages e10â€“e52, https://doi.org/10.1093/cid/ciu296 \n \n \nFigure 9.1: Approach to management of patients with SSTI \n",
  "tables": [],
  "italic_text": [
    "Clinical Infectious Diseases"
  ],
  "dimensions": {
    "width": 595.3200073242188,
    "height": 841.9199829101562
  }
}